Search

everythinglearnresearchcommunity

for

Search:↓

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Suppressing ODC activity reduces tumor growth in hair follicles.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

Antizyme slows skin tumor growth by reducing cell growth in mice.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.